Citrus aurantium patents
This article was originally published in The Tan Sheet
Executive SummaryPatent & Trademark Office issues three patents to Zhishin for Advantra Z citrus aurantium extract for weight loss, physical performance, according to Nutratech, the ingredient's exclusive worldwide licensee. Patented claims include "increasing the ratio of lean muscle to total body mass," "improving athletic performance" and "suppressing appetite," in addition to earlier patented claim for "stimulating thermogenesis and reducing weight." Advantra Z is found in USANA, Natrol and Twinlab products; ingredient soon will appear in NBTY supplements as well. Acknowledging presence of other, potentially infringing citrus aurantium products on market, Nutratech says it will take any "necessary action" to protect its intellectual property rights...
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.